(Q53531226)
Statements
Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer. (English)
Satoshi Igawa
Nobuyuki Yamamoto
Shinya Ueda
Akira Ono
Yukiko Nakamura
Asuka Tsuya
Haruyasu Murakami
Masahiro Endo
Toshiaki Takahashi
1 August 2007
2
8
741-744